HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$1.15
Day range
$1.11 - $1.19
Year range
$0.88 - $2.57
Market cap
64.30M USD
Avg Volume
524.99K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 2.57M | 286.02% |
Operating expense | 5.99M | -25.39% |
Net income | -22.98M | 35.83% |
Net profit margin | -895.09 | 83.38% |
Earnings per share | -0.18 | 37.93% |
EBITDA | -21.14M | 41.29% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 152.41M | -47.47% |
Total assets | 228.79M | -38.35% |
Total liabilities | 105.67M | -18.81% |
Total equity | 123.12M | — |
Shares outstanding | 56.90M | — |
Price to book | 0.53 | — |
Return on assets | -22.26% | — |
Return on capital | -23.92% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -22.98M | 35.83% |
Cash from operations | -32.00M | -16.74% |
Cash from investing | 14.83M | -45.67% |
Cash from financing | 73.00K | -99.84% |
Net change in cash | -17.10M | -137.52% |
Free cash flow | -23.41M | -68.13% |
About
Founded
2018
Headquarters
Website
Employees
142
